| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 52.034 | 53.943 | - | 74.713 | 102.212 | 104.149 | 115.221 | 128.125 | 135.278 | 142.474 |
| Total Income - EUR | 52.036 | 54.087 | - | 74.713 | 102.213 | 105.010 | 115.221 | 128.125 | 135.504 | 142.474 |
| Total Expenses - EUR | 45.754 | 42.883 | - | 69.235 | 95.544 | 90.163 | 100.823 | 97.550 | 107.655 | 117.148 |
| Gross Profit/Loss - EUR | 6.281 | 11.204 | - | 5.478 | 6.669 | 14.846 | 14.398 | 30.575 | 27.849 | 25.325 |
| Net Profit/Loss - EUR | 4.720 | 10.122 | - | 4.731 | 5.647 | 13.880 | 13.384 | 29.319 | 26.657 | 21.692 |
| Employees | 5 | 2 | - | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Finas Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 371 | 1.223 | - | 874 | 707 | 546 | 395 | 308 | 930 | 1.216 |
| Current Assets | 11.778 | 11.977 | - | 33.630 | 43.674 | 55.632 | 71.453 | 33.002 | 59.658 | 80.743 |
| Inventories | 0 | 2 | - | 6 | 3 | 3 | 7 | 13 | 6 | 6 |
| Receivables | 7.566 | 4.947 | - | 14.288 | 11.910 | 27.989 | 53.435 | 3.903 | 27.843 | 41.367 |
| Cash | 4.213 | 7.028 | - | 19.336 | 31.761 | 27.640 | 18.011 | 29.086 | 31.809 | 39.371 |
| Shareholders Funds | 6.840 | 11.548 | - | 26.935 | 32.060 | 45.332 | 57.711 | 29.368 | 55.936 | 77.315 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.309 | 2.454 | - | 7.569 | 12.321 | 10.846 | 14.137 | 3.942 | 4.652 | 4.645 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Finas Medical Srl